Investor profile
Cape Fear BioCapital
Seed-stage therapeutics fund launched 2024.
Directory portfolio
Companies connected here
4
Incyclix Bio
Selective CDK2 inhibitor developer advancing INX-315 for CDK4/6-resistant ER+/HER2- breast cancer and CCNE1-amplified solid tumors.
iOrganBio
AI-powered cell manufacturing platform for human cell production
Ten63 Therapeutics
AI platform for cancer drug discovery
Thoracic Innovations
Medical device company developing surgical tools for cardiothoracic disease
Portfolio coverage reflects public company-investor links tracked in this directory and may not represent the investor's full portfolio.